A Case of Interstitial Pneumonitis and Pancytopenia Following the Combination Therapy of Pegylated Interferon and Ribavirin / 결핵및호흡기질환
Tuberculosis and Respiratory Diseases
; : 69-73, 2011.
Article
在 Ko
| WPRIM
| ID: wpr-136335
Responsible library:
WPRO
ABSTRACT
The combination therapy of pegylated interferon and ribavirin is the mainstay of treatment for chronic hepatitis C patients. Anti-viral therapy is commonly associated with side effects such as headache, fever, myalgia, and arthralgia. However, anti-viral therapy can continue because these side effects are mostly mild and can be improved with supportive management. Anti-viral therapy should be stopped promptly if serious side effects, such as interstitial pneumonitis or hemolytic anemia occur, although those serious side effects are rare. There were a few case reports of interferon-related interstitial pneumonitis worldwide. In Korea, one atypical case report of interstitial pneumonitis has been reported, which followed the combination therapy of interferon-alpha and ribavirin in a patient with chronic hepatitis C. We present a case of interstitial pneumonitis and pancytopenia following the combination therapy of pegylated interferon and ribavirin in a patient with chronic hepatitis C.
Key words
全文:
1
索引:
WPRIM
主要主题:
Pancytopenia
/
Polyethylene Glycols
/
Ribavirin
/
Recombinant Proteins
/
Interferons
/
Interferon-alpha
/
Lung Diseases, Interstitial
/
Arthralgia
/
Hepatitis C, Chronic
/
Fever
限制:
Humans
国家/地区名称主题:
Asia
语言:
Ko
期刊:
Tuberculosis and Respiratory Diseases
年:
2011
类型:
Article